Nemolizumab‐induced exacerbation of atopic dermatitis
The Journal of Dermatology · 2025-04 · 52 (4)
DOI: 10.1111/1346-8138.17589 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Dermatology, online erschienen am 19.12.2024. Verfasst von Hirofumi Kamada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Iwate Medical University School of Medicine, Morioka, Japan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, Iwate Medical University School of Medicine, Morioka, Japan.
- Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine, Morioka, Japan.
ORCID-Profile: Hirofumi Kamada, Daisuke Watabe
Zitieren
APA
Kamada, H., Arakawa, N., Kato, M., Tanji, T., Watabe, D., Yanagawa, N., & Amano, H. (2025). Nemolizumab‐induced exacerbation of atopic dermatitis. The Journal of Dermatology, 52(4). https://doi.org/10.1111/1346-8138.17589
Vancouver
Kamada H, Arakawa N, Kato M, Tanji T, Watabe D, Yanagawa N, et al. Nemolizumab‐induced exacerbation of atopic dermatitis. The Journal of Dermatology. 2025;52(4). doi:10.1111/1346-8138.17589
BibTeX
@article{Kamada2025,
author = {Kamada, Hirofumi and Arakawa, Nobuyuki and Kato, Marino and Tanji, Takayuki and Watabe, Daisuke and Yanagawa, Naoki and Amano, Hiroo},
title = {Nemolizumab‐induced exacerbation of atopic dermatitis},
journal = {The Journal of Dermatology},
year = {2025},
volume = {52},
number = {4},
doi = {10.1111/1346-8138.17589}
}
EUVIMED